Investigation of availability of solifenacin succinate on effect insufficiency cases by b3 receptor agonist -Switching study from mirabegron to solifenacin-
Phase of Trial: Phase IV
Latest Information Update: 16 Sep 2016
Price : $35 *
At a glance
- Drugs Solifenacin (Primary)
- Indications Overactive bladder
- Focus Therapeutic Use
- Acronyms WATCH
- 16 Sep 2016 Results (n=27) presented at the 46th Annual Meeting of the International Continence Society
- 11 Apr 2016 Status changed from active, no longer recruiting to completed.
- 02 Apr 2015 Status changed from recruiting to active, no longer recruiting as reported by University Hospital Medical Information Network - Japan.